Tg Therapeutics (TGTX) Invested Capital (2010 - 2026)
Tg Therapeutics (TGTX) posted quarterly Invested Capital of $975000.0 for Q4 2021, down 95.6% year-over-year from $22.2 million in Q4 2020, and down 93.91% quarter-over-quarter from $16.0 million in Q3 2021.
Powered by 
Analysis
Tg Therapeutics (TGTX) Invested Capital (2010 - 2026) Analysis & Trends
Tg Therapeutics' Invested Capital history runs 2 years deep, the most recent figure standing at $975000.0 for Q4 2021.
- In Q4 2021, Invested Capital fell 95.6% year-over-year to $975000.0; the TTM figure through Sep 2022 stood at $975000.0 (down 98.93% YoY), while the FY2021 annual figure was $975000.0, down 95.6% from the prior year.
- Invested Capital for Q4 2021 stood at $975000.0, down from $16.0 million in the prior quarter.
- The five-year high for Invested Capital was $30.1 million in Q1 2021, with the low at $975000.0 in Q4 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 33.70 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 7.35 Bn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 6.25 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 19.13 Bn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 1.30 Bn |
| 10 | Tg Therapeutics | 7.97 Bn | 7.29 Bn | 199.14 Mn | 1.35 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.35 Bn |
| Mar 31, 2026 | 1.33 Bn |
| Dec 31, 2025 | 893.67 Mn |
| Sep 30, 2025 | 852.56 Mn |
| Jun 30, 2025 | 521.47 Mn |
| Mar 31, 2025 | 482.02 Mn |
| Dec 31, 2024 | 466.79 Mn |
| Sep 30, 2024 | 436.32 Mn |
| Jun 30, 2024 | 280.11 Mn |
| Mar 31, 2024 | 261.44 Mn |
| Dec 31, 2023 | 260.62 Mn |
| Sep 30, 2023 | 263.68 Mn |
| Jun 30, 2023 | 138.15 Mn |
| Mar 31, 2023 | 123.94 Mn |
| Dec 31, 2022 | 129.72 Mn |
| Sep 30, 2022 | 171.62 Mn |
| Jun 30, 2022 | 197.98 Mn |
| Mar 31, 2022 | 237.64 Mn |
| Dec 31, 2021 | 304.92 Mn |
| Sep 30, 2021 | 327.52 Mn |